Skip to main content

Table 5 Health effects, costs and cost effectiveness of migraine management strategies in China, India, Russian Federation and Zambia

From: Cost-effectiveness analysis of interventions for migraine in four low- and middle-income countries

  

China

India

Russian Federation

Zambia

 

Target coverage*

Healthy life years gained per year (per 1 m popn)

 

Cost per year per capita (US$)

 

Cost per healthy life year gained (US$)

 

ICER (US$)

Healthy life years gained per year (per 1 m popn)

 

Cost per year per capita (US$)

 

Cost per healthy life year gained (US$)

 

ICER (US$)

Healthy life years gained per year (per 1 m popn)

 

Cost per year per capita (US$)

 

Cost per healthy life year gained (US$)

 

ICER (US$)

Healthy life years gained per year (per 1 m popn)

 

Cost per year per capita (US$)

 

Cost per healthy life year gained (US$)

 

ICER (US$)

A. ACUTE MANAGEMENT (NON-SPECIFIC DRUGS)

Simple analgesics (e.g. ASA 1 g)

90%

530

$

0.02

$

34

$

35

673

$

0.05

$

73

$

75

1223

$

0.07

$

53

$

63

1244

$

0.03

$

24

$

24

With consumer education

 

597

$

0.03

$

53

$

204

757

$

0.06

$

77

$

105

1376

$

0.19

$

136

$

801

1400

$

0.12

$

85

$

575

B. ACUTE MANAGEMENT (SPECIFIC DRUGS)

Sumatriptan (50 mg)

90%

152

$

2.14

$

14,061

  

193

$

1.20

$

6,201

  

352

$

12.55

$

35,684

  

358

$

2.62

$

7,330

  

With consumer education

 

212

$

2.16

$

10,159

  

269

$

1.21

$

4,485

  

490

$

12.67

$

25,869

  

498

$

2.71

$

5,442

  

With provider training

 

178

$

2.16

$

12,129

  

226

$

1.20

$

5,335

  

410

$

12.64

$

30,804

  

417

$

2.64

$

6,329

  

With consumer education and provider training

 

248

$

2.17

$

8,762

  

314

$

1.21

$

3,859

  

571

$

12.76

$

22,330

  

581

$

2.73

$

4,698

  

Almotriptan (12.5 mg)

90%

196

$

5.59

$

28,546

  

249

$

14.55

$

58,533

  

452

$

23.38

$

51,728

  

460

$

8.82

$

19,187

  

With consumer education

 

273

$

5.61

$

20,544

  

346

$

14.56

$

42,049

  

630

$

23.51

$

37,332

  

640

$

8.91

$

13,915

  

With provider training

 

229

$

5.61

$

24,528

  

290

$

14.56

$

50,187

  

527

$

23.47

$

44,508

  

536

$

8.84

$

16,482

  

With consumer education and provider training

 

318

$

5.62

$

17,652

  

404

$

14.56

$

36,053

  

735

$

23.60

$

32,121

  

747

$

8.93

$

11,953

  

C. ACUTE STEPPED CARE MANAGEMENT

ASA (1 g) + sumatriptan (50 mg)

90%

431

$

2.52

$

5,840

  

547

$

1.62

$

2,964

  

994

$

15.71

$

15,811

  

1011

$

2.95

$

2,917

  

With consumer education

 

600

$

2.53

$

4,215

  

761

$

1.63

$

2,139

  

1384

$

15.84

$

11,440

  

1408

$

3.04

$

2,158

  

With provider training

 

503

$

2.53

$

5,033

  

638

$

1.62

$

2,548

  

1160

$

15.80

$

13,630

  

1179

$

2.97

$

2,517

  

With consumer education and provider training

 

700

$

2.54

$

3,633

$

24,271

888

$

1.63

$

1,839

$

11,996

1615

$

15.93

$

9,861

$

65,920

1643

$

3.06

$

1,861

$

12,102

D. PROPHYLAXIS + ACUTE MANAGEMENT

ASA (1 g) + amitriptyline (100 mg)

30%

112

$

0.18

$

1,649

  

145

$

0.26

$

1,795

  

275

$

1.45

$

5,264

  

305

$

0.24

$

773

  

With consumer education

 

189

$

0.20

$

1,047

  

245

$

0.27

$

1,098

  

465

$

1.57

$

3,377

  

515

$

0.32

$

631

  

With provider training

 

130

$

0.20

$

1,517

  

169

$

0.26

$

1,565

  

321

$

1.54

$

4,790

  

355

$

0.25

$

716

  

With consumer education and provider training

 

220

$

0.21

$

959

  

286

$

0.27

$

957

  

543

$

1.66

$

3,059

  

601

$

0.34

$

573

  

Sumatriptan (50 mg) + amitriptyline (100 mg)

30%

49

$

0.73

$

14,872

  

63

$

0.53

$

8,329

  

121

$

3.95

$

32,633

  

134

$

1.09

$

8,102

  

With consumer education

 

83

$

0.74

$

8,962

  

107

$

0.54

$

5,010

  

205

$

4.07

$

19,902

  

227

$

1.18

$

5,188

  

With provider training

 

68

$

0.74

$

10,908

  

88

$

0.53

$

6,049

  

168

$

4.04

$

24,027

  

186

$

1.11

$

5,937

  

With consumer education and provider training

 

115

$

0.76

$

6,571

  

149

$

0.54

$

3,637

  

284

$

4.16

$

14,644

  

315

$

1.19

$

3,796

  

ASA + sumatriptan + amitriptyline

30%

103

$

0.80

$

7,740

  

133

$

0.73

$

5,467

  

248

$

4.55

$

18,319

  

275

$

1.20

$

4,362

  

With consumer education

 

174

$

0.81

$

4,657

  

226

$

0.74

$

3,273

  

420

$

4.67

$

11,128

  

465

$

1.29

$

2,773

  

With provider training

 

143

$

0.81

$

5,668

  

185

$

0.73

$

3,961

  

345

$

4.64

$

13,449

  

382

$

1.22

$

3,191

  

With consumer education and provider training

 

241

$

0.82

$

3,409

  

313

$

0.74

$

2,371

  

583

$

4.76

$

8,166

  

645

$

1.31

$

2,026

  
  1. *Target coverage for acute management in Zambia set at 80%.
  2. ICER=Incremental cost-effectiveness ratio. All interventions without an ICER value are 'dominated’.